Innospec Inc.

Industrials
Major Chemicals
www.innospecinc.com

Earnings Score
Moat Score

Market Cap $2.90B
PE 20
Debt $NaN
Cash $303.80M
EV $NaN
FCF $NaN

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$143.80M
EBIT	$189.10M
ROE	12%
ROA	11%
Equity	$1.25B
Growth Stability	33%
PE	20.13
PEG	0.73
PB	2.32
P/S	1.55
Price/Cash	0.1
Net Margins	8%
Gross Margins	30%
Op. Margins	10%
Earnings CAGR	5%
Sales Growth YoY	-4%
Sales Growth QoQ	2%
Sales CAGR	9%
Equity CAGR	9%
Earnings Stability	0.08
Earnings Growth YoY	-15%
Earnings Growth QoQ	7%

Earnings CAGR 5Y	27%
Sales CAGR 5Y	11%
Equity CAGR 5Y	7%
Earnings CAGR 3Y	7%
Sales CAGR 3Y	7%
Equity CAGR 3Y	6%
Market Cap	$2.90B
Revenue	$1.87B
Dividend Yield	1%
Payout Ratio	26%
Assets	$1.80B
Cash	$303.80M
Shares Outstanding	24.93M
Earnings Score	7%
Moat Score	90%
Working Capital	592.5M
Current Ratio	2.59
Gross Profit	$562.40M
Shares Growth 3y	0%
Equity Growth QoQ	4%
Equity Growth YoY	11%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

SEC Filings

Direct access to Innospec Inc. (IOSP) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Innospec Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Innospec Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 5%

Stability 8%

loading chart...

Innospec Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Innospec Inc..

Years

Calculation mode

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
DCF		$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Value	$0

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	9%	12%	9%	5%	6%	7%	2%	6%	7%	7%	8%
ROA	-	15%	9%	9%	9%	10%	3%	9%	12%	10%	11%
ROE	-	20%	12%	8%	10%	12%	3%	9%	13%	12%	12%

Net Margins (7.69%)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	1.33	-	-	-	-	-	-	-	-	-
Debt over Equity	0.27	0.22	0.43	0.29	0.28	0.06	0	-	-	-	-
Growth Stability	-	-	-	65%	97%	100%	33%	100%	100%	100%	33%

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Neutral Debt/Equity ratio (-)

The company has a balance between equity and debt that is not too good nor too bad.

Bad Graham’s Stability (33%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2014	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	5%	-13%	48%	13%	2%	-21%	24%	32%	-1%	11%
Earnings YoY growth	-	42%	-32%	-24%	38%	32%	-74%	224%	43%	5%	27%
Equity YoY growth	-	17%	8%	21%	4%	11%	3%	9%	1%	10%	7%
FCF YoY growth	-	8%	-	-	-	-	-	-	-	-	-